Analysis of immune system and inflammatory molecules in cardiac disease.

Analysis of immune system and inflammatory molecules in cardiac disease. - Cardiac disease and immune system

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000012049

Enrollment

250

Registered

2013-11-01

Start date

2012-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac disease (acute coronary syndrome, angina pectoris, valvular disease, heart failure, arrhythmia, and so on)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy volunteers and patients with cardiac disease who agree to this study.

Exclusion criteria

Exclusion criteria: Patients who do not agree to this study and those who are not appropriate for this study.

Design outcomes

Primary

Measure	Time frame
The discrepancy of immune system, inflammatory molecules, and gut microbiota between cardiac disease patients and healthy volunteers.	—

Countries

Japan

Contacts

Public ContactTomoya Yamashita

Kobe University Hospital Department of cardiology

tomoya@med.kobe-u.ac.jp078-382-5846

Outcome results